The most exciting products and services are coming from small healthcare startups that are using technology to deliver agile, transparent, and quality-driven healthcare.
Healthcare startups have raised more than $2 billion in equity in just the last quarter of 2020, according to data from CB Insights. Below are some health-tech startups that dominated the healthcare industry in 2020.
British digital health startup Heal X specializes in research in rare diseases. It won an award for the best AI product in health and outstanding achievement in social good use of AI in 2020 from CogX.
Its push for innovation in expertise sharing and AI has seen new treatments moving to the clinic stage in under two years. HealX’s team comprises next-generation drug hunters, AI experts, and bioinformaticians. The startup raised $56 million in its Series B funding round in October 2019.
Ada Health is a Berlin-based start-up that was founded by Claire Novorol, Martin Hirsch and Daniel Nathrath in 2011. The company has offices in Munich, London and New York too.
Ada Health has doctors and scientists as founding members who have used artificial intelligence and medical knowhow to help users manage their health.
It was one of the pioneers in bringing telemedicine to the forefront. Since the firm was founded in 2011, it has raised more than €60m in funding and attracted 10m users who have completed 15m health assessments.
HealthCrowd is a SaaS platform for healthcare communications. The San Mateo, CA-based maker of an enterprise platform for digital patient communications, analytics and machine learning. HealthCrowd is currently defining the mobile health messaging market in the U.S.
Freenome, a biotechnology health startup, has pioneered a comprehensive multiomics platform for early cancer detection with a routine blood draw It works at the junction of biology, machine learning, and medicine. Its team comprises of programmers, ML experts, computational biologists, and clinicians.
Their Multiomics platform is designed to discover cancer in its foundational stages and help medical professionals optimize the next generation of precision therapies. Freenome has raised a total of $507.6 million.
Alector is pioneering the cure for neurodegeneration through immuno-neurology. It was started in 2013. Alector’s investigations and programs center around the brain’s immune system to combat diseases such as Alzheimer’s and dementia. The healthcare startup went public in February 2019 and raised approximately $176 million in its initial public offering.